Altered Habenula Activity following Ketamine Administration in Treatment-Resistant Major Depression

被引：0

作者：

Carlson, Paul J. ^{[1
,2
]}

DiazGranados, Nancy ^{[3
]}

Nugent, Allison ^{[4
]}

Ibrahim, Lobna ^{[4
]}

Luckenbaugh, David ^{[4
]}

Tinsley, Ruth ^{[4
]}

Brutsche, Nancy ^{[4
]}

Herscovitch, Peter ^{[5
]}

Manji, Husseini K. ^{[6
,7
]}

Zarate, Carlos A. ^{[4
]}

Drevets, Wayne C. ^{[8
]}

机构：

[1] Salt Lake VAMC, Salt Lake City, UT USA

[2] Univ Utah, Sch Med, Salt Lake City, UT USA

[3] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA

[4] NIMH, Expt Therapeut & Pathophysiol Branch, DIRP, NIH, Bethesda, MD 20892 USA

[5] NIH, Positron Emiss Tomog Dept, Ctr Clin, Bethesda, MD 20892 USA

[6] CNS, Titusville, NJ USA

[7] Pain Johnson & Johnson, Titusville, NJ USA

[8] Univ Oklahoma, Laureate Inst Brain Res, Coll Med, Tulsa, OK USA

来源：

BIOLOGICAL PSYCHIATRY | 2011年 / 69卷 / 09期

关键词：

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

537

引用

页码：160S / 161S

页数：2

共 50 条

[1] Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
Rivas-Grajales, Ana Maria
Salas, Ramiro
Robinson, Meghan E.
Qi, Karen
Murrough, James W.
Mathew, Sanjay J.
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (05): : 383 - 391
[2] Magnesium in Ketamine Administration in Treatment-Resistant Depression
Gorska, Natalia
Cubala, Wieslaw Jerzy
Slupski, Jakub
Wiglusz, Mariusz Stanislaw
Galuszko-Wegielnik, Maria
Kawka, Mateusz
Grzegorzewska, Agata
[J]. PHARMACEUTICALS, 2021, 14 (05)
[3] Noninferior to ketamine for treatment-resistant major depression without psychosis
Lampl, Benedikt M. J.
[J]. ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2024, 59 (05):
[4] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
Niciu, Mark J.
Luckenbaugh, David A.
Ionescu, Dawn F.
Guevara, Sara
Machado-Vieira, Rodrigo
Richards, Erica M.
Brutsche, Nancy E.
Zarate, Carlos A.
[J]. BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 128S - 128S
[5] Intravenous ketamine therapy in a patient with a treatment-resistant major depression
Liebrenz, Michael
Borgeat, Alain
Leisinger, Ria
Stohler, Rudolf
[J]. SWISS MEDICAL WEEKLY, 2007, 137 (15-16) : 234 - 236
[6] Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Anand, A.
Mathew, S. J.
Sanacora, G.
Murrough, J. W.
Goes, F. S.
Altinay, M.
Aloysi, A. S.
Asghar-Ali, A. A.
Barnett, B. S.
Chang, L. C.
Collins, K. A.
Costi, S.
Iqbal, S.
Jha, M. K.
Krishnan, K.
Malone, D. A.
Nikayin, S.
Nissen, S. E.
Ostroff, R. B.
Reti, I. M.
Wilkinson, S. T.
Wolski, K.
Hu, B.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25): : 2315 - 2325
[7] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
Niciu, Mark J.
Luckenbaugh, David A.
Ionescu, Dawn F.
Guevara, Sara
Machado-Vieira, Rodrigo
Richards, Erica M.
Brutsche, Nancy E.
Nolan, Neal M.
Zarate, Carlos A., Jr.
[J]. JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (05) : E417 - E423
[8] Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Souza, Sergio A.
Josino, Taina R.
Bisol, Luisa W.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (10): : 959 - 962
[9] The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
Hashimoto, Kenji
[J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2014, 12 (01) : 72 - 73
[10] In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response
Holsinger, Tracey
Riordan, Paul
[J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (09) : JC105 - JC105

← 1 2 3 4 5 →